Study shows PromarkerD ability to also predict late-stage kidney decline in type-2 diabetes patients
The Company is pleased to announce the results of a study demonstrating the potential ability of...
PromarkerD latest results published in peer reviewed journal
Latest PromarkerD clinical validation results published in the Journal of Diabetes and its Complications.
PromarkerD is the first test globally capable of predicting the onset of diabetic kidney disease.
In the 447 patient study, PromarkerD correctly predicted 86% of those who went on to develop chronic kidney disease (CKD) within four years.